Put companies on watchlist
European Healthcare Acquisition & Growth Company B.V.
ISIN: NL0015000K10
WKN: A3C60V
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

European Healthcare Acquisition & Growth Company B.V. · ISIN: NL0015000K10 · EQS - Company News (44 News)
Country: Germany · Primary market: Netherlands · EQS NID: 1381675
23 June 2022 10:55AM

General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions


DGAP-News: European Healthcare Acquisition & Growth Company B.V. / Key word(s): Miscellaneous
General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions (news with additional features)

23.06.2022 / 10:55
The issuer is solely responsible for the content of this announcement.


General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions

Amsterdam, 23 June 2022

European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam aiming to acquire one or more companies in the European healthcare sector, announces that its annual general meeting of shareholders has adopted all resolutions at the annual general meeting of shareholders held today at 10:00 CEST, by means of a virtual meeting ("AGM").

The adopted resolutions include the adoption of the financial statements for the financial year 2021, the discharge from liability of the directors and the reappointment of Deloitte Accounts B.V. as independent external auditor entrusted with the audit of the financial statements for the financial year 2022.

The voting results from the AGM will be published on the website of EHC in the 'Investor Relations' section under 'Shareholder Meeting': www.ehc-company.com. The minutes will be made available on the Company's website within three months.

European Healthcare Acquisition & Growth Company B.V.

General Enquiries
+49 (0) 89 4523240
info@ehc-company.com

Media Enquiries
Finsbury Glover Hering
Kai Peter Rath
+49 211 43079-209
kai.rath@fgh.com

Disclaimer
This press release may include forward-looking statements, which are based on EHC's current expectations and projections about future events and speak only as of the date hereof. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not within or outside the control of EHC. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. accordingly, no undue reliance should be placed on any forward-looking statements. EHC operates in a rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor to assess the impact that these factors will have on EHC. Forward-looking statements speak only as at the date at which they are made and EHC undertakes no obligation to update these forward-looking statements.

This press release contains information that may qualify as inside information within the meaning of Article 7, paragraph 1, of the EU Market Abuse Regulation.


Additional features:

File: 2022 EHC Press Release AGM Results


23.06.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: European Healthcare Acquisition & Growth Company B.V.
c/o ALR Treuhand GmbH; Theresienhöhe 28
80339 München
Germany
ISIN: NL0015000K10, NL00115000K28
WKN: A3C60V
Listed: Amsterdam
EQS News ID: 1381675

 
End of News DGAP News Service

1381675  23.06.2022 

fncls.ssp?fn=show_t_gif&application_id=1381675&application_name=news&site_id=boersengefluester
Visual performance / price development - European Healthcare Acquisition & Growth Company B.V.
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.